Norepinephrine supplemented with dobutamine or epinephrine for the cardiovascular support of patients with septic shock

Indian Journal of Critical Care Medicine

Volumn 16, Issue 2, 2012, Pages 75-80

  Mahmoud, Khaled ^a   Ammar, Amany ^a  

^a Minoufiya Faculty of Medicine   (Egypt)

Author keywords

Cardiovascular support; dobutamine; epinephrine; norepinephrine; septic shock

Indexed keywords

ADRENALIN; DOBUTAMINE; LACTIC ACID; NORADRENALIN;

ACUTE CORONARY SYNDROME; ADD ON THERAPY; ADULT; ARTERIAL PH; ARTICLE; CENTRAL VENOUS PRESSURE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DRUG DOSE INCREASE; FEMALE; FLUID THERAPY; HEART ARRHYTHMIA; HEART EJECTION FRACTION; HEART INDEX; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART RATE; HUMAN; LACTATE BLOOD LEVEL; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; SEPTIC SHOCK; SYSTEMIC VASCULAR RESISTANCE; URINE VOLUME;

EID: 84864838600     PISSN: 09725229     EISSN: 1998359X     Source Type: Journal    
DOI: 10.4103/0972-5229.99110     Document Type: Article

References (25)

1. Shapiro NI, Howell M, Talmor D. A blue print for a sepsis protocol. Acad Emerg Med 2005;12:352-9.
2. Blanco J, Muriel-Bombín A, Sagredo V, Taboada F, Gandía F, Tamayo L, et al. Incidence, organ dysfunction and mortality in severe sepsis: A Spanish multicentre study. Crit Care 2008;12:R158.
3. Makwana N, Baines PB. Myocardial dysfunction in meningococcal septic shock. Curr Opin Crit Care 2005;11:418-23.
4. Ragaller M. Microcirculation in sepsis and septic shock-therapeutic options? Anaesthesiol Intensivmed Notfallmed Schmerzther 2008;43:48-53.
5. Lin SM, Huang CD, Lin HC, Liu CY, Wang CH, Kuo HP. A modified goal-directed protocol improves clinical outcomes in intensive care unit patients with septic shock: A randomized controlled trial. Shock 2006;26:551-7.
6. Nfor TK, Walsh TS, Prescott RJ. The impact of organ failures and their relationship with outcome in intensive care: Analysis of a prospective multicentre database of adult admissions. Anaesthesia 2006;61:731-8.
7. Vieillard Baron A, Schmitt JM, Beauchet A, Augarde R, Prin S, Page B, et al. Early preload adaptation in septic shock? A transesophageal echocardiographic study. Anesthesiology 2001;94:400-6.
8. Beale RJ, Hollenberg SM, Vincent JL, Parrillo JE. Vasopressor and inotropic support in septic shock: An evidence-based review. Crit Care Med 2004;32:S455-65.
9. Myburgh JA. An appraisal of selection and use of catecholamines in septic shock - old becomes new again. Crit Care Resusc 2006;8:353-60.
10. Jones AE, Brown MD, Trzeciak S, Shapiro NI, Garrett JS, Heffner AC, et al. The effect of a quantitative resuscitation strategy on mortality in patients with sepsis: A meta-analysis. Crit Care Med 2008;36:2734-9.
11. Rudis MI, Rowland KL. Current concepts in severe sepsis and septic shock. J Pharmacol Pract 2005;18:351-62.
12. Hernandez G, Bruhn A, Romero C, Larrondo FJ, De La Fuente R, Cornejo R, et al. Implementation of a norepinephrine-based protocol for management of septic shock: A pilot feasibility study. J Trauma 2006;60:77-81.
13. Annane D, Vignon P, Renault A, Bollaert PE, Charpentier C, Martin C, et al. Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: A randomized trial. Lancet 2007; 370:676-84.
14. Minneci PC, Deans KJ, Banks SM, Costello R, Csako G, Eichacker PQ, et al. Differing effects of epinephrine, norepinephrine and vasopressin on survivals in a canine model of septic shock. Am J Physiol Heart Cric Physiol 2004;287:H 2545-54.
15. Kreijci V, Hiltebrand LB, Sigurdsson GH. Effects of epinephrine, norepinephrine and phenylephrine on microcirculation blood flow in the gastrointestinal tract in sepsis. Crit Care Med 2006;34:1456-63.
16. Martikainen TJ, Uusaro A, Tenhunen JJ, Ruokonen E. Dobutamine compensates deleterious hemodynamic and metabolic effects of vasopressin in the splanchnic region in endotoxin shock. Acta Anaesthesiol Scand 2004;48:935-43.
17. Dries DJ. Cardiovascular support in septic shock. Air Med J 2007;26:240-7.
18. Wilson W, Lipman J, Scribante J, Kobilski S, Lee C, Krause P, et al. Septic shock: Does adrenaline have a role as a first-line inotropic agent? Anaesth Intensive Care 1992;20:470-4.
19. Moran JL, O'Fathartaigh MS, Peisach AR, Chapman MJ, Leppard P. Epinephrine as an inotropic agent in septic shock: A dose-profile analysis. Crit Care Med 1993;21:70-7.
20. Le Tulzo Y, Seguin P, Gacouin A, Camus C, Suprin E, Jouannic I, et al. Effects of epinephrine on right ventricular function in patients with severe septic shock and right ventricular failure: A preliminary descriptive study. Intensive Care Med 1997;23:664-70.
21. Seguin P, Laviolle B, Guinet P, Morel I, Mallédant Y, Bellissant E. Dopexamine and norepinephrine versus epinephrine on gastric perfusion in patients with septic shock: A randomized study. Crit Care 2006;10:R32.
22. Durantea J, Sitbon P, Teboul JL, Vicaut E, Anguel N, Richard C, et al. The effect of epinephrine, norepinephrine or the combination of norepinephrine and dobutamine on gastric mucosa in septic shock. Crit Care Med 1999;27:893-900.
23. Levy B. Lactate and shock: The metabolic view. Curr Opin Crit Care 2006;12:315-21.
24. Levy B, Gibot S, Franke P, Cravoisy A, Bollaert PE. Relation between muscle Na+ K+ ATPase and raised lactate concentration in septic shock: A prospective study. Lancet 2005;365:871-5.
25. Bourgoin A, Leone M, Delmas A, Garnier F, Albanèse J, Martin C. Increasing mean arterial pressure in patients with septic shock: Effects on oxygen variables and renal function. Crit Care Med 2005;33:780-6.